CR20140437A - Vacuna de combinacion contra pcv/mycoplasma hyopneumoniae - Google Patents
Vacuna de combinacion contra pcv/mycoplasma hyopneumoniaeInfo
- Publication number
- CR20140437A CR20140437A CR20140437A CR20140437A CR20140437A CR 20140437 A CR20140437 A CR 20140437A CR 20140437 A CR20140437 A CR 20140437A CR 20140437 A CR20140437 A CR 20140437A CR 20140437 A CR20140437 A CR 20140437A
- Authority
- CR
- Costa Rica
- Prior art keywords
- mycoplasma hyopneumoniae
- vaccine against
- combination vaccine
- against pcv
- hyo
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La presente invención proporciona una composición inmunogénica que incluye una porción soluble de una preparación de células enteras de Mycoplasma hyopneumoniae (M.hyo), en la que la porción soluble de la preparación de M.hyo está sustancialmente libre de (i) IgG y (ii) inmunocomplejos compuestos por antígeno unido a inmunoglobulina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261620175P | 2012-04-04 | 2012-04-04 | |
PCT/US2013/035088 WO2013152083A2 (en) | 2012-04-04 | 2013-04-03 | Pcv/mycoplasma hyopneumoniae combination vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
CR20140437A true CR20140437A (es) | 2014-11-10 |
Family
ID=48182999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR20140437A CR20140437A (es) | 2012-04-04 | 2014-09-22 | Vacuna de combinacion contra pcv/mycoplasma hyopneumoniae |
Country Status (33)
Country | Link |
---|---|
US (5) | US9125885B2 (es) |
EP (2) | EP3508218A1 (es) |
JP (1) | JP6271503B2 (es) |
KR (3) | KR20180049221A (es) |
CN (1) | CN104334186B (es) |
AR (1) | AR090615A1 (es) |
AU (1) | AU2013243537B2 (es) |
BR (1) | BR112014024785B1 (es) |
CA (1) | CA2869594C (es) |
CL (1) | CL2014002675A1 (es) |
CO (1) | CO7160025A2 (es) |
CR (1) | CR20140437A (es) |
CY (1) | CY1121998T1 (es) |
DK (1) | DK2833910T3 (es) |
ES (1) | ES2721925T3 (es) |
HK (1) | HK1206609A1 (es) |
HR (2) | HRP20140954A2 (es) |
HU (1) | HUE043322T2 (es) |
LT (1) | LT2833910T (es) |
MX (2) | MX336503B (es) |
MY (1) | MY174622A (es) |
NI (1) | NI201400119A (es) |
PH (1) | PH12014502251B1 (es) |
PL (1) | PL2833910T3 (es) |
PT (1) | PT2833910T (es) |
RS (1) | RS58481B1 (es) |
RU (1) | RU2615443C2 (es) |
SI (1) | SI2833910T1 (es) |
TR (1) | TR201904603T4 (es) |
TW (1) | TWI602574B (es) |
UA (1) | UA114503C2 (es) |
WO (1) | WO2013152083A2 (es) |
ZA (1) | ZA201406974B (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA114504C2 (uk) * | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs |
UA114503C2 (uk) * | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv та mycoplasma hyopneumoniae |
US9120859B2 (en) * | 2012-04-04 | 2015-09-01 | Zoetis Services Llc | Mycoplasma hyopneumoniae vaccine |
UA121097C2 (uk) * | 2012-12-28 | 2020-04-10 | Бьорінгер Інгельхайм Ветмедіка Гмбх | Імуногенна композиція, що містить антигени мікоплазм |
AU2013370983B2 (en) | 2012-12-28 | 2019-09-26 | Boehringer Ingelheim Vetmedica Gmbh | Method of making a mycoplasma vaccine |
WO2014182872A1 (en) | 2013-05-08 | 2014-11-13 | Protatek International, Inc. | Vaccine for pcv2 and mycoplasma |
CN104248759B (zh) * | 2013-11-19 | 2017-05-10 | 普莱柯生物工程股份有限公司 | 一种疫苗组合物及其制备方法和应用 |
US10130698B2 (en) | 2013-12-03 | 2018-11-20 | Intervet Inc. | Vaccine against porcine circo virus type 2 |
EP3673916A1 (en) * | 2013-12-03 | 2020-07-01 | Intervet International B.V. | Vaccine against lawsonia intracellularis and porcine circovirus2 |
US9713639B2 (en) * | 2014-05-19 | 2017-07-25 | Merial, Inc. | Recombinant spike protein subunit based vaccine for porcine epidemic diarrhea virus (PEDV) |
BR112017012220A2 (pt) | 2014-12-11 | 2018-01-30 | Intervet Int Bv | processos para preparar uma composição de antígeno e uma vacina, composição de antígeno, vacina, usos de uma composição de antígeno e de uma vacina, e, método para prevenção ou redução de infecção por um vírus em suíno e sinais associados à doença. |
RU2018137034A (ru) * | 2016-03-23 | 2020-04-23 | Интервет Интернэшнл Б.В. | Комбинированная вакцина против вируса pcv2 и инфекции mycoplasma hyopneumoniae |
BR112018069219A2 (pt) * | 2016-03-23 | 2019-01-22 | Intervet Int Bv | uma vacina para aplicação intradérmica contra infecção pelo vírus pcv2 e prrs |
JP6931059B2 (ja) | 2016-12-23 | 2021-09-01 | インターベット インターナショナル ベー. フェー. | 豚用混合ワクチン |
CN106668855B (zh) * | 2017-02-03 | 2020-11-24 | 四川省华派生物制药有限公司 | 猪肺炎支原体灭活疫苗与猪瘟活疫苗组合疫苗及其制备方法 |
CN110446502B (zh) * | 2017-04-13 | 2024-01-26 | 英特维特国际股份有限公司 | 用于联合非混合使用的含猪病原体的疫苗 |
CN109010818B (zh) * | 2017-06-09 | 2021-11-09 | 普莱柯生物工程股份有限公司 | 一种预防和/或治疗猪圆环病毒感染的二联疫苗组合物及其制备方法和应用 |
CN109125719B (zh) * | 2017-06-19 | 2022-06-14 | 普莱柯生物工程股份有限公司 | 一种含猪圆环病毒3型、猪圆环病毒2型抗原的免疫原性组合物及其应用 |
CN109207502B (zh) * | 2018-10-10 | 2021-08-10 | 浙江洪晟生物科技股份有限公司 | 猪支原体肺炎和猪圆环病毒2型重组蛋白及制备二联疫苗 |
CN109234418B (zh) * | 2018-11-20 | 2021-08-13 | 湖南中净生物科技有限公司 | 一种鉴别猪肺炎支原体野毒株和疫苗株的引物、试剂盒和方法 |
CN112294953A (zh) * | 2020-12-31 | 2021-02-02 | 北京科牧丰生物制药有限公司 | 一种pcv2型杆状病毒载体、猪肺炎支原体、副猪嗜血杆菌三联灭活疫苗及制备方法 |
WO2022186661A1 (ko) * | 2021-03-04 | 2022-09-09 | 주식회사 이노백 | 돼지 마이코플라스마균 및 돼지 써코바이러스 감염 예방을 위한 다가 백신 조성물 |
KR102646305B1 (ko) * | 2021-03-04 | 2024-03-13 | 주식회사 이노백 | 돼지 마이코플라스마균 및 돼지 써코바이러스 감염 예방을 위한 다가 백신 조성물 |
Family Cites Families (75)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB228811A (en) | 1924-11-04 | 1925-02-12 | Congoleum Company Inc | Improvements in stands or racks for displaying rolled merchandise |
US4606918A (en) | 1983-08-22 | 1986-08-19 | Syntex (U.S.A.) Inc. | Polyoxypropylene-polyoxyethylene block polymer based adjuvants |
US4681870A (en) * | 1985-01-11 | 1987-07-21 | Imre Corporation | Protein A-silica immunoadsorbent and process for its production |
CA1267087A (en) | 1985-02-14 | 1990-03-27 | Nicolaas Visser | Synthetic immunogen |
US5084269A (en) | 1986-11-06 | 1992-01-28 | Kullenberg Fred W | Adjuvant for dose treatment with antigens |
DE3875762T2 (de) | 1987-03-17 | 1993-05-13 | Akzo Nv | Adjuvanzienmischung. |
EP0283840A3 (en) | 1987-03-26 | 1989-08-09 | Ml Technology Ventures, L.P. | Mycoplasma hyopneumoniae antigen and uses therefor |
US5252328A (en) | 1987-03-26 | 1993-10-12 | Martin Marietta Energy Systems, Inc. | Mycoplasma hyopneumoniae antigen and uses therefor |
CA1338618C (en) | 1987-11-03 | 1996-10-01 | Noelene E. Byars | Vaccine adjuvant |
US4985243A (en) | 1988-01-20 | 1991-01-15 | Ml Technology Ventures, L.P. | Composition and method for protecting against diseases caused by microorganisms |
US5240706A (en) | 1989-04-07 | 1993-08-31 | Ml Technology Ventures, L.P. | Intranasal administration of Mycoplasma hyopneumoniae antigen |
ZA906806B (en) | 1989-08-31 | 1991-06-26 | Ici Australia Operations | Plants |
WO1991018627A1 (en) | 1990-05-29 | 1991-12-12 | Smithkline Beecham Corporation | Swine pneumonia vaccine and method for the preparation thereof |
US6113916A (en) | 1990-05-29 | 2000-09-05 | American Cyanamid Company | Method of enhancing cell mediated immune responses |
US5695769A (en) | 1990-06-13 | 1997-12-09 | Pfizer Inc. | Pasteurella multocida toxoid vaccines |
US5565205A (en) | 1990-08-16 | 1996-10-15 | Solvay Animal Health, Inc. | Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof |
DE69201441T3 (de) | 1991-06-06 | 2008-12-04 | Boehringer Ingelheim Vetmedica Gmbh | Erreger der mysteriösen schweinekrankheit,impfstoff-zusammensetzungen und diagnose kits. |
DK0601062T4 (da) | 1991-08-26 | 2001-03-14 | Univ Minnesota | SIRS-vaccine og diagnosefremgangsmåde |
ATE131067T1 (de) | 1991-10-14 | 1995-12-15 | Akzo Nobel Nv | Impfstoff gegen das fortpflanzungs- und atmungssyndrom bei schweinen (prrs) und diagnose. |
ES2194841T3 (es) | 1991-11-15 | 2003-12-01 | Pfizer | Procedimiento de produccion de vacunas bacterianas gram negativas. |
FR2686097B1 (fr) | 1992-01-14 | 1994-12-30 | Rhone Merieux | Preparation d'antigenes et de vaccins de virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie. |
US5338543A (en) | 1992-02-27 | 1994-08-16 | Ambico, Inc. | Thimerosal inactivated mycoplasma hyopneumoniae vaccine |
US5534256A (en) | 1992-07-02 | 1996-07-09 | University Of Saskatchewan | Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins |
US6251397B1 (en) | 1992-10-30 | 2001-06-26 | Iowa State University Research Foundation, Inc. | Proteins encoded by polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus and immunogenic compositions containing the same |
US6592873B1 (en) | 1992-10-30 | 2003-07-15 | Iowa State University Research Foundation, Inc. | Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids |
US6380376B1 (en) | 1992-10-30 | 2002-04-30 | Iowa State University Research Foundation | Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
US5695766A (en) | 1992-10-30 | 1997-12-09 | Iowa State University Research Foundation | Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome |
US6773908B1 (en) | 1992-10-30 | 2004-08-10 | Iowa State University Research Foundation, Inc. | Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
ES2074950B1 (es) | 1993-09-17 | 1996-03-16 | Iberica Cyanamid | Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda. |
BR9507717A (pt) | 1994-05-10 | 1997-09-23 | American Home Prod | Vacina brsv viva modificada aperfeiçoada |
BE1008978A5 (fr) | 1994-12-27 | 1996-10-01 | Solvay | Adjuvants pour vaccins. |
US5788962A (en) | 1995-01-17 | 1998-08-04 | The Curators Of The University Of Missouri | DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures |
AUPN178995A0 (en) * | 1995-03-16 | 1995-04-13 | University Of Melbourne, The | Antigen composition |
US5820869A (en) | 1995-06-07 | 1998-10-13 | American Home Products Corporation | Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
DE19601754A1 (de) | 1996-01-19 | 1997-07-24 | Hoechst Ag | Dictyocaulus viviparus Antigen zur Diagnose des Lungenwurmbefalls und zur Vakzinierung |
US5846735A (en) | 1996-04-18 | 1998-12-08 | University Of Iowa Research Foundation | Hepatitis C virus Fc-binding function |
GB9622159D0 (en) | 1996-10-24 | 1996-12-18 | Solvay Sociutu Anonyme | Polyanionic polymers as adjuvants for mucosal immunization |
EP0839912A1 (en) | 1996-10-30 | 1998-05-06 | Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
BR9714160A (pt) | 1996-12-20 | 2000-05-02 | Univ Texas | Antìgenos uspa1 e uspa2 de moraxella catarrhalis |
WO1999026664A1 (en) | 1997-11-26 | 1999-06-03 | Iowa State University Research Foundation, Inc. | Recombinant mycoplasma hyopneumoniae vaccine |
FR2772047B1 (fr) | 1997-12-05 | 2004-04-09 | Ct Nat D Etudes Veterinaires E | Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection |
US6342231B1 (en) | 1998-07-01 | 2002-01-29 | Akzo Nobel N.V. | Haemophilus parasuis vaccine and diagnostic |
CA2440933A1 (en) | 1998-12-22 | 2000-06-22 | Pfizer Products Inc. | An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof |
US6632439B2 (en) | 1999-09-29 | 2003-10-14 | Novartis Animal Health, Inc. | Fusobacterium necrophorum vaccine and method for making such vaccine |
US6585981B1 (en) | 2000-07-27 | 2003-07-01 | Regents Of The University Of Minnesota | Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae |
US7018638B2 (en) | 2000-12-19 | 2006-03-28 | Wyeth | Mycoplasma hyopneumoniae bacterin vaccine |
MY129765A (en) | 2000-12-19 | 2007-04-30 | Wyeth Corp | Improved mycoplasma hyopneumoniae bacterin vaccine |
JP2005515162A (ja) | 2001-07-02 | 2005-05-26 | ファイザー・プロダクツ・インク | マイコプラズマ・ハイオニューモニエ(Mycoplasmahyopneumoniae)を用いた単回ワクチン接種 |
JP2004537543A (ja) * | 2001-07-02 | 2004-12-16 | ファイザー・プロダクツ・インク | マイコプラズマ・ハイオニューモニエ・ワクチンおよび牛におけるマイコプラズマ・ボビス低減方法 |
US7279166B2 (en) * | 2001-12-12 | 2007-10-09 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
US7276353B2 (en) | 2001-12-12 | 2007-10-02 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
EP1546357B1 (en) | 2002-06-28 | 2013-08-07 | Iowa State University Research Foundation, Inc. | Immunogenic mycoplasma hyopneumoniae polypeptides |
CA2533581C (en) * | 2003-07-24 | 2012-05-08 | Merial Limited | Vaccine formulations comprising an oil-in-water emulsion |
RU2007130801A (ru) | 2005-01-13 | 2009-02-20 | Берингер Ингельхайм Ветмедика Гмбх (De) | Улучшенные вакцины против репродуктивно-респираторного синдрома свиней (prrs) |
UA95458C2 (ru) * | 2005-09-09 | 2011-08-10 | Интервет Интернешонал Б.В. | Вакцина против pcv-2 у mda-положительных поросят |
EP1792996A1 (en) | 2005-12-01 | 2007-06-06 | Consejo Superior de Investigaciones Cientificas | Nucleic acid sequences encoding vaccines against Porcine reproductive and respiratory syndrome virus (PRRSV) |
WO2007094893A2 (en) * | 2005-12-29 | 2007-08-23 | Boehringer Ingelheim Vetmedica, Inc. | Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs |
RU2488407C2 (ru) | 2005-12-29 | 2013-07-27 | Берингер Ингельхайм Ветмедика, Инк. | Поливалентные иммуногенные композиции pcv2 и способы получения таких композиций |
ATE535253T1 (de) * | 2006-04-10 | 2011-12-15 | Intervet Int Bv | Impfstoff gegen mycoplasma prrsv |
WO2007116032A1 (en) | 2006-04-10 | 2007-10-18 | Intervet International B.V. | Vaccine against mycoplasma prrsv |
PL2094872T5 (pl) * | 2006-12-15 | 2020-10-05 | Boehringer Ingelheim Animal Health USA Inc. | Leczenie świń seropozytywnych wobec przeciwciała anty-pcv2 antygenem pcv2 |
DK2217271T3 (en) * | 2007-11-06 | 2016-06-06 | Zoetis Services Llc | Avirulent, live vaccine with adjuvant against Mycoplasma hyopneumoniae |
CA2712006A1 (en) * | 2008-01-23 | 2009-10-15 | Boehringer Ingelheim Vetmedica, Inc. | Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions |
TWI449533B (zh) | 2008-04-18 | 2014-08-21 | Intervet Int Bv | 防備胞內勞森菌(Lawsonia intracellularis)、豬肺炎黴漿菌(Mycoplasma hyopneumoniae)及豬環狀病毒(Porcine circo virus)用疫苗 |
US8444989B1 (en) | 2008-04-18 | 2013-05-21 | Boehringer Ingelheim Vetmedica Gmbh | One dose vaccination against mycoplasma infections of pigs |
EP2356132A2 (en) | 2008-10-16 | 2011-08-17 | Pfizer Inc. | Torque teno virus (ttv) isolates and compositions |
FI20096134A0 (fi) | 2009-11-03 | 2009-11-03 | Pulse Finland Oy | Säädettävä antenni |
WO2011141443A1 (en) | 2010-05-11 | 2011-11-17 | Intervet International B.V. | Vaccine against mycoplasma hyopneumoniae, suitable for administration in the presence of maternally derived antibodies |
WO2012025612A1 (en) | 2010-08-27 | 2012-03-01 | Intervet International B.V. | Potency test for vaccine formulations |
US8546149B2 (en) | 2010-08-27 | 2013-10-01 | Intervet Inc. | Potency test for vaccine formulations |
UA108902C2 (uk) | 2010-11-10 | 2015-06-25 | Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування | |
UA115053C2 (uk) | 2012-03-07 | 2017-09-11 | Сева Санте Анімаль | Композиція, що містить антиген і ліпополісахарид у формі масло-в-воді, та спосіб її використання (варіанти) |
UA114503C2 (uk) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv та mycoplasma hyopneumoniae |
UA114504C2 (uk) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs |
US9120859B2 (en) * | 2012-04-04 | 2015-09-01 | Zoetis Services Llc | Mycoplasma hyopneumoniae vaccine |
-
2013
- 2013-03-04 UA UAA201410838A patent/UA114503C2/uk unknown
- 2013-03-26 US US13/850,329 patent/US9125885B2/en active Active
- 2013-04-02 TW TW102111966A patent/TWI602574B/zh active
- 2013-04-03 ES ES13718432T patent/ES2721925T3/es active Active
- 2013-04-03 MY MYPI2014702901A patent/MY174622A/en unknown
- 2013-04-03 KR KR1020187012298A patent/KR20180049221A/ko not_active Application Discontinuation
- 2013-04-03 DK DK13718432.1T patent/DK2833910T3/en active
- 2013-04-03 PL PL13718432T patent/PL2833910T3/pl unknown
- 2013-04-03 WO PCT/US2013/035088 patent/WO2013152083A2/en active Application Filing
- 2013-04-03 AU AU2013243537A patent/AU2013243537B2/en active Active
- 2013-04-03 TR TR2019/04603T patent/TR201904603T4/tr unknown
- 2013-04-03 LT LTEP13718432.1T patent/LT2833910T/lt unknown
- 2013-04-03 MX MX2014012015A patent/MX336503B/es unknown
- 2013-04-03 SI SI201331403T patent/SI2833910T1/sl unknown
- 2013-04-03 RU RU2014140106A patent/RU2615443C2/ru active
- 2013-04-03 KR KR20147030865A patent/KR20150003259A/ko not_active Application Discontinuation
- 2013-04-03 CN CN201380023651.6A patent/CN104334186B/zh active Active
- 2013-04-03 EP EP19156797.3A patent/EP3508218A1/en active Pending
- 2013-04-03 PT PT13718432T patent/PT2833910T/pt unknown
- 2013-04-03 EP EP13718432.1A patent/EP2833910B1/en not_active Revoked
- 2013-04-03 JP JP2015504699A patent/JP6271503B2/ja active Active
- 2013-04-03 KR KR1020177011554A patent/KR102003620B1/ko active IP Right Grant
- 2013-04-03 BR BR112014024785-4A patent/BR112014024785B1/pt active IP Right Grant
- 2013-04-03 HU HUE13718432A patent/HUE043322T2/hu unknown
- 2013-04-03 CA CA2869594A patent/CA2869594C/en active Active
- 2013-04-03 RS RS20190382A patent/RS58481B1/sr unknown
- 2013-04-04 AR ARP130101116 patent/AR090615A1/es not_active Application Discontinuation
-
2014
- 2014-09-22 CR CR20140437A patent/CR20140437A/es unknown
- 2014-09-23 ZA ZA2014/06974A patent/ZA201406974B/en unknown
- 2014-10-03 CO CO14219838A patent/CO7160025A2/es unknown
- 2014-10-03 MX MX2015015486A patent/MX354759B/es unknown
- 2014-10-03 CL CL2014002675A patent/CL2014002675A1/es unknown
- 2014-10-03 PH PH12014502251A patent/PH12014502251B1/en unknown
- 2014-10-03 HR HRP20140954AA patent/HRP20140954A2/hr not_active Application Discontinuation
- 2014-10-03 NI NI201400119A patent/NI201400119A/es unknown
-
2015
- 2015-05-14 US US14/712,426 patent/US9649369B2/en active Active
- 2015-07-27 HK HK15107171.9A patent/HK1206609A1/xx unknown
-
2017
- 2017-04-06 US US15/480,973 patent/US10206993B2/en active Active
-
2019
- 2019-01-15 US US16/248,239 patent/US10668145B2/en active Active
- 2019-03-22 HR HRP20190563TT patent/HRP20190563T1/hr unknown
- 2019-04-24 CY CY20191100446T patent/CY1121998T1/el unknown
-
2020
- 2020-04-28 US US16/860,308 patent/US11154609B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20140437A (es) | Vacuna de combinacion contra pcv/mycoplasma hyopneumoniae | |
CO7160026A2 (es) | Vacuna contra mycoplasma hyopneumoniae | |
CO7160027A2 (es) | Vacuna de combinación contra pcv/mycoplasma hyopneumoniae/srrp | |
BR112015004515A2 (pt) | composição imunogênica | |
BR112014013876A2 (pt) | vacina à base de toxina de clostridium difficile | |
UA116697C2 (uk) | Композиція для запобігання зараженню видами роду mycoplasma | |
CL2015001659A1 (es) | Composición inmunogénica que comprende antígenos de mycoplasma | |
BR112016012393A2 (pt) | Vacina, e, uso de uma combinação de um vírus prrs atenuado vivo e um antígeno de lawsonia intracellularis inativado | |
BR112012022680A2 (pt) | métodos para proteger um animal um canino contra doença, e, uso de uma vacina contra vírus da influenza canina | |
BR112018007918A2 (pt) | vacina, uso de antígeno de lawsonia intracellularis inativada, e, método para proteger um animal. |